<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
83444-301-10
</NDCCode>
<PackageDescription>
1 VIAL, GLASS in 1 CARTON (83444-301-10) / 5 mL in 1 VIAL, GLASS
</PackageDescription>
<NDC11Code>
83444-0301-10
</NDC11Code>
<ProductNDC>
83444-301
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Unloxcyt
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Cosibelimab
</NonProprietaryName>
<DosageFormName>
INJECTION, SOLUTION
</DosageFormName>
<RouteName>
INTRAVENOUS
</RouteName>
<StartMarketingDate>
20250630
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
BLA
</MarketingCategoryName>
<ApplicationNumber>
BLA761297
</ApplicationNumber>
<LabelerName>
Checkpoint Therapeutics, Inc.
</LabelerName>
<SubstanceName>
COSIBELIMAB
</SubstanceName>
<StrengthNumber>
300
</StrengthNumber>
<StrengthUnit>
mg/5mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2025-12-04
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20251231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20250630
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>